Salix Pharmaceuticals and the Italian parent company of Cosmo Technologies said they had terminated their merger agreement, amid a crackdown on so-called inversion deals.
via WSJ.com: US Business http://ift.tt/YXWU36
via WSJ.com: US Business http://ift.tt/YXWU36
Nessun commento:
Posta un commento